These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1769497

  • 1. [Isolation of factor IX concentrate from cryosupernatant of donor's plasma].
    Fetisova LV, Viazova EP, Khametova RN, Shuvalova AL, Azhigirova MA, Lazarev VA, Zeĭnalov AM.
    Gematol Transfuziol; 1991 Jun; 36(6):34-6. PubMed ID: 1769497
    [Abstract] [Full Text] [Related]

  • 2. Preparation and properties of a therapeutic factor IX concentrate.
    Suomela H, Myllylä G, Raaska E.
    Vox Sang; 1977 Jul; 33(1):37-50. PubMed ID: 883244
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T, Michalski C, Goudemand M, Huart JJ.
    Vox Sang; 1989 Jul; 57(4):225-32. PubMed ID: 2617959
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A factor IX-concentrate for the treatment of haemophilia B].
    Suomela H, Myllylä G.
    Duodecim; 1971 Jul; 87(1):31-8. PubMed ID: 5539580
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM, Veltkamp JJ.
    Thromb Haemost; 1978 Oct 31; 40(2):335-49. PubMed ID: 734633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Substitution treatment of hemophilia a and b.
    Duckert F.
    Schweiz Med Wochenschr; 1975 Jun 14; 105(24):783-4. PubMed ID: 1145162
    [Abstract] [Full Text] [Related]

  • 15. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
    Najaf SM, Malik A, Quraishi AU, Kazmi K, Kakepoto GN.
    Ann Hematol; 2004 Sep 14; 83(9):604-7. PubMed ID: 15205916
    [Abstract] [Full Text] [Related]

  • 16. Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography.
    Iberer G, Schwinn H, Josic D, Jungbauer A, Buchacher A.
    J Chromatogr A; 2002 Sep 27; 972(1):115-29. PubMed ID: 12395951
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human factor IX inhibitors: immunochemical characteristics and treatment with activated concentrate.
    Giddings JC, Bloom AL, Kelly MA, Spratt HC.
    Clin Lab Haematol; 1983 Sep 27; 5(2):165-75. PubMed ID: 6603957
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.